Under construction – not a live service
Sign in
Taking people in SwedenNo phase

Tests a total diet replacement with eHealth or in-person follow-up in type 2 diabetes

Tests a total diet replacement for weight loss in adults with type 2 diabetes.

Plain-language title generated from the registry record
Registry title: The eHealth Diabetes Remission Trial

Key facts

Where
Jönköping, Örnsköldsvik, and Umeå, SwedenSee the 3 sites

Could this be for you?

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 20 and 70 years old?

Source: NCT05491005, who can take part

Where in Sweden

  • Bra Liv Råslätt vårdcentralJönköping, SwedenTaking people
  • Örnsköldsvik hospitalÖrnsköldsvik, SwedenNot yet recruiting
  • Department of Public Health and Clinical Medicine, MedicineUmeå, SwedenTaking people

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
Umeå University
Trial code
NCT05491005
Record updated
30 April 2026
Original description
Overweight patients with type 2 diabetes are offered a total diet replacement with the goal of weight loss and diabetes remission. Study participants are randomised to eHealth follow-up or face-to-face follow-up, but the dietary advice is the same in both groups. A healthy control group with normal glucose tolerance is examined once but is not randomised and does not receive any intervention.Read full original descriptionShow less

eHealth Diabetes Remission Trial (Swedish: Remission av Typ 2 Diabetes Med hjälp av eHälsa

Overweight patients with type 2 diabetes are offered a total diet replacement with the goal of weight loss and diabetes remission. Study participants are randomised to eHealth follow-up or face-to-face follow-up, but the dietary advice is the same in both groups. A healthy control group with normal glucose tolerance is examined once but is not randomised and does not receive any intervention.

Inclusion: Type 2 diabetes with duration 0-6 years; BMI 27 kg/m2 and higher; HbA1c 43 mmol/mol or higher (48 or higher if without diabetes medication).

Exclusion: Treatment with antipsychotic drugs; Diagnosed eating disorder; Myocardial infarction last six months; Severe heart failure (NYHA class III); Ongoing cancer; eGFR < 30 ml/min/1,73m2; Insulin treatment; Weight loss more than 5 kg during the past 6 months; Pregnancy.

ClinicalTrials.gov NCT05491005